Abstract: We report on recent experimental results on beta decay into self-conjugate ( N = Z) nuclei with mass number 58 <= A <= 70. Super-allowed b decays from the J(pi) = 0(+) ground state of a Z = N + 2 parent nucleus are to the isobaric analogue state through so-called Fermi transitions and to J(pi) = 1(+) states by way of Gamow-Teller (GT) transitions. The operator of the latter decay is a generator of Wigner's SU(4) algebra and as a consequence GT transitions obey selection rules associated with this symmetry. Since SU(4) is progressively broken with increasing A, mainly as a consequence of the spinorbit interaction, this symmetry is not relevant for the nuclei considered here. We argue, however, that the pseudo-spin-orbit splitting can be small in nuclei with 58 <= A <= 70, in which case nuclear states exhibit an approximate pseudo-SU(4) symmetry. To test this conjecture, GT decay strength is calculated with use of a schematic Hamiltonian with pseudo-SU(4) symmetry. Some generic features of the GT beta decay due to pseudo-SU(4) symmetry are pointed out. The experimentally observed GT strength indicates a restoration of pseudo-SU(4) symmetry for A = 70.

Abstract: The lack of evidence for new physics at the Large Hadron Collider so far has prompted the development of model-independent search techniques. In this study, we compare the anomaly scores of a variety of anomaly detection techniques: an isolation forest, a Gaussian mixture model, a static autoencoder, and a beta-variational autoencoder (VAE), where we define the reconstruction loss of the latter as a weighted combination of regression and classification terms. We apply these algorithms to the 4-vectors of simulated LHC data, but also investigate the performance when the non-VAE algorithms are applied to the latent space variables created by the VAE. In addition, we assess the performance when the anomaly scores of these algorithms are combined in various ways. Using supersymmetric benchmark points, we find that the logical AND combination of the anomaly scores yielded from algorithms trained in the latent space of the VAE is the most effective discriminator of all methods tested.

Abstract: The neutron-rich Pb-213 isotope was produced in the fragmentation of a primary 1 GeV A U-238 beam, separated in FRS in mass and atomic number, and then implanted for isomer decay gamma-ray spectroscopy with the RISING setup at GSI. A newly observed isomer and its measured decay properties indicate that states in Pb-213 are characterized by the seniority quantum number that counts the nucleons not in pairs coupled to angular momentum J = 0. The conservation of seniority is a consequence of a geometric phase associated with particle-hole conjugation, which becomes observable in semi-magic nuclei where nucleons half-fill the valence shell. The gamma-ray spectroscopic observables in Pb-213 are thus found to be driven by two mechanisms, particle-hole conjugation and seniority conservation, which are intertwined through a Berry phase.

Abstract: Purpose This work aims to simulate clustered DNA damage from ionizing radiation and estimate the relative biological effectiveness (RBE) for radionuclide (rBT)- and electronic (eBT)-based surface brachytherapy through a hybrid Monte Carlo (MC) approach, using realistic models of the sources and applicators. Methods Damage from ionizing radiation has been studied using the Monte Carlo Damage Simulation algorithm using as input the primary electron fluence simulated using a state-of-the-art MC code, PENELOPE-2018. Two Ir-192 rBT applicators, Valencia and Leipzig, one Co-60 source with a Freiburg Flap applicator (reference source), and two eBT systems, Esteya and INTRABEAM, have been included in this study implementing full realizations of their geometries as disclosed by the manufacturer. The role played by filtration and tube kilovoltage has also been addressed. Results For rBT, an RBE value of about 1.01 has been found for the applicators and phantoms considered. In the case of eBT, RBE values for the Esteya system show an almost constant RBE value of about 1.06 for all depths and materials. For INTRABEAM, variations in the range of 1.12-1.06 are reported depending on phantom composition and depth. Modifications in the Esteya system, filtration, and tube kilovoltage give rise to variations in the same range. Conclusions Current clinical practice does not incorporate biological effects in surface brachytherapy. Therefore, the same absorbed dose is administered to the patients independently on the particularities of the rBT or eBT system considered. The almost constant RBE values reported for rBT support that assumption regardless of the details of the patient geometry, the presence of a flattening filter in the applicator design, or even significant modifications in the photon energy spectra above 300 keV. That is not the case for eBT, where a clear dependence on the eBT system and the characteristics of the patient geometry are reported. A complete study specific for each eBT system, including detailed applicator characteristics (size, shape, filtering, among others) and common anatomical locations, should be performed before adopting an existing RBE value.

Abstract: Three different correction factors for measurements with the parallel-plate ionization chamber PTW T34013 on the Esteya electronic brachytherapy unit have been investigated. This chamber type is recommended by AAPM TG-253 for depth-dose measurements in the 69.5 kV x-ray beam generated by the Esteya unit. Monte Carlo simulations using the PENELOPE-2018 system were performed to determine the absorbed dose deposited in water and in the chamber sensitive volume at different depths with a Type A uncertainty smaller than 0.1%. Chamber-to-chamber differences have been explored performing measurements using three different chambers. The range of conical applicators available, from 10 to 30 mm in diameter, has been explored. Using a depth-independent global chamber perturbation correction factor without a shift of the effective point of measurement yielded differences between the absorbed dose to water and the corrected absorbed dose in the sensitive volume of the chamber of up to 1% and 0.6% for the 10 mm and 30 mm applicators, respectively. Calculations using a depth-dependent perturbation factor, including or excluding a shift of the effective point of measurement, resulted in depth-dose differences of about +/- 0.5% or less for both applicators. The smallest depth-dose differences were obtained when a shift of the effective point of measurement was implemented, being displaced 0.4 mm towards the center of the sensitive volume of the chamber. The correction factors were obtained with combined uncertainties of 0.4% (k = 2). Uncertainties due to chamber-to-chamber differences are found to be lower than 2%. The results emphasize the relevance of carrying out detailed Monte Carlo studies for each electronic brachytherapy device and ionization chamber used for its dosimetry.